Industry association · Austria · EU Transparency Register 098025935611-30
2
positions filed
in the 326 files tracked
1
legislative file
of 326 tracked
1
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 1205 trade and business associations on this site, they rank #823 by legislative files engaged — a count of participation, not a measure of influence.
2
declared lobbying FTE
self-declared
€100K+
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2019
in the register since
Declares membership of
Mitgliedschaft bei der IFPMA (International Federation of Pharmaceutical Manufacturers & Associations)
Unterstützung weiterer Organisationen sind auf der Homepage unter Transparenz aufgelistet (pro Kalenderjahr): https:/…
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).
Register category
Trade and business associations
Registered as
PHARMIG - Verband der pharmazeutischen Industrie Österreichs (PHARMIG)
Head office
Wien, Austria
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
PHARMIG filed 2 positions between 11 Jun 2025 and 31 Jul 2026, across 1 of the 326 legislative files tracked here, attaching a full position paper 1 time.
PHARMIG, the Austrian Pharmaceutical Industry Association, welcomes in principle the European Commission’s proposal on the European Biotech Act I (Proposal for a Regulation of the European Parliament and of the Council establishing a framework of measures for strengthening biotechnology and biomanufacturing in the Union, in particular in the field of health, and amending Regulations (EC) No 178/2002, (EC) No…
Filed in German · English published by the European Commission
PHARMIG, the voluntary representation of the Austrian pharmaceutical industry, strongly supports the objective of the announced European Biotech Act: Creating a world-class innovation environment for biotechnologies! Among other things, PHARMIG is working to maximise the potential of the competitive pharmaceutical sector.
Filed in German · English published by the European Commission
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Is this your organization?
Everything on this page comes from PHARMIG’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.